Cereno Scientific
6.13 SEK
-1.13 %
Less than 1K followers
CRNO B
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Valuation
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Cereno Scientific
P/B
Median 2019-2025
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Share price (SEK) | 3.43 | 2.04 | 5.08 | 2.26 | 4.58 | 5.50 | 6.99 |
| Shares | 40.2 | 40.2 | 105.3 | 137.5 | 233.8 | 281.7 | 310.5 |
| Market cap | 138.0 | 81.8 | 534.7 | 310.1 | 1,069.5 | 1,549.4 | 2,170.3 |
| Enterprise value | 112.3 | 25.4 | 450.3 | 243.5 | - | - | - |
| EV/S | 10.2 | - | - | - | - | - | - |
| EV/EBITDA | neg. | neg. | neg. | neg. | - | - | - |
| EV/EBIT | neg. | neg. | neg. | neg. | - | - | - |
| P/E | neg. | neg. | neg. | neg. | neg. | neg. | neg. |
| P/B | 2.31 | 0.82 | 3.14 | 1.54 | 4.95 | 8.07 | 8.60 |
| P/S | 12.5 | - | - | - | - | - | - |
| Dividend yield | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % |
| Equity ratio | 93.1 % | 88.9 % | 94.1 % | 93.4 % | 75.9 % | 46.4 % | 62.7 % |
| Gearing ratio | 0.7 % | 9.5 % | 3.1 % | 0.2 % | 21.0 % | 99.2 % | 49.5 % |